GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Charles River Laboratories
Charles River Laboratories is a contract research organization (CRO) providing preclinical testing services to the pharmaceutical industry. Its stock price is a barometer of the health of the biotech sector, as R&D volumes directly impact demand for its services.
Share prices of companies in the market segment - Pharma tests
Charles River Labs operates in the preclinical research segment, providing services to the pharmaceutical industry. We classify it as part of the Pharmaceutical Testing sector. The chart below shows the dynamics of this segment, which serves as a barometer of R&D activity in biotech.
Broad Market Index - GURU.Markets
Charles River Laboratories is one of the world's largest contract research organizations (CROs), providing preclinical research services to pharmaceutical companies. Its industry weight earns it a spot in the GURU.Markets index. The chart below compares its performance to the market.
Change in the price of a company, segment, and market as a whole per day
CRL - Daily change in the company's share price Charles River Laboratories
Shares of Charles River Labs, a preclinical research company for pharmaceutical companies, exhibit volatility related to the volume of R&D investments in biotech. Daily price changes are a measure of this sensitivity. This metric is important for analyzing the state of the entire pharmaceutical industry on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Pharma tests
Charles River Laboratories International, Inc. is a contract research organization (CRO). This chart shows the average daily volatility of the healthcare sector. Compared to CRL, whose revenue depends on pharmaceutical companies' R&D budgets, it serves as a barometer of innovation.
Daily change in the price of a broad market stock, index - GURU.Markets
Charles River Laboratories is a contract research organization (CRO) providing preclinical research services to the pharmaceutical industry. Its business serves as a barometer of activity in the global pharmaceutical industry. The chart below shows general market fluctuations, which can be used to assess the sector's stability.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Charles River Laboratories
Charles River is a giant in the pharmaceutical services market, from preclinical research to cell therapy manufacturing. Its annual growth rate serves as a barometer of R&D investment in the biotech industry. The chart below tells the story of this science-intensive business.
Annual dynamics of market capitalization of the market segment - Pharma tests
Charles River Laboratories International, Inc. is a contract research organization (CRO) that plays a key role in preclinical drug development. Its outsourcing services are essential to the entire pharmaceutical industry. The chart shows how its dominant position and growing R&D spending in the pharmaceutical industry enable its stable growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Charles River Laboratories provides drug development services, making it a gold mine in the biotech world. Demand for its services is stable, as pharmaceutical companies spend on R&D throughout the economic cycle. Its stock price often shows smoother and more predictable growth than the overall market.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Charles River Laboratories
The value of Charles River, a contract research organization (CRO), depends on the R&D cycles in the pharmaceutical industry. The monthly fluctuations on the chart reflect demand for its preclinical research services, which is a leading indicator of drug development activity.
Monthly dynamics of market capitalization of the market segment - Pharma tests
This chart shows the dynamics of the pharmaceutical services sector. For Charles River, a leader in preclinical research operations (CRO), this provides context. Its growth reflects outsourcing trends in R&D and the continued demand for its services.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Charles River Laboratories is a contract research organization (CRO) that provides services across all stages of drug development, from preclinical studies to manufacturing. The chart below shows overall market sentiment. Charles River's performance is driven by biotech investment, serving as a barometer for the health of the entire pharmaceutical industry.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Charles River Laboratories
Charles River Laboratories, a preclinical research provider, is a barometer of pharmaceutical R&D activity. Weekly stock price movements reflect funding news for biotech startups and general trends in drug development.
Weekly dynamics of market capitalization of the market segment - Pharma tests
Charles River Laboratories, as a contract research organization, reflects the overall state of R&D in the pharmaceutical industry. Investments in new drug development and the activity of biotech startups create overall demand for its services. The graph will show whether CRL is moving in sync with the industry or whether its scale allows it to grow faster than the market.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
As a key partner to the pharmaceutical industry, Charles River can move independently of the broader market. Demand for its preclinical research services is driven by biotech R&D cycles, not the state of the economy. The chart will show how often CRL ignores overall market sentiment and follows its own news agenda.
Market capitalization of the company, segment and market as a whole
CRL - Market capitalization of the company Charles River Laboratories
Charles River Laboratories' market capitalization chart reflects the behind-the-scenes workings of the pharmaceutical industry. The company assists in preclinical drug development, and its chart shows how investors view the volume of R&D in biotech. Its growth suggests that more and more potential new drugs are being developed.
CRL - Share of the company's market capitalization Charles River Laboratories within the market segment - Pharma tests
Charles River Laboratories is an outsourcing giant providing preclinical research services to pharmaceutical companies. Its share of the sector's market capitalization reflects its indispensable role in the drug development process. The chart below shows how its valuation correlates with the size of R&D budgets in the global pharmaceutical industry.
Market capitalization of the market segment - Pharma tests
Charles River Laboratories provides preclinical research services to pharmaceutical companies. The chart below shows the market capitalization of the contract research sector. This is an estimate of the industry that helps accelerate and reduce the cost of developing new, life-saving drugs.
Market capitalization of all companies included in a broad market index - GURU.Markets
Charles River Laboratories is an outsourcing company providing preclinical research services to the pharmaceutical industry. Its market capitalization reflects the importance of its role in the drug development process. Market-wide, its value reflects the weight of the behind-the-scenes, yet critical, work required to validate the safety and efficacy of future drugs.
Book value capitalization of the company, segment and market as a whole
CRL - Book value capitalization of the company Charles River Laboratories
Charles River Labs' book value represents its global laboratory network. It reflects the value of its research centers, animal facilities, and sophisticated equipment required for preclinical testing of new drugs across the pharmaceutical industry. The chart below shows how the company has expanded its scientific and material foundation, becoming an indispensable partner in R&D.
CRL - Share of the company's book capitalization Charles River Laboratories within the market segment - Pharma tests
Charles River Laboratories conducts preclinical research using an extensive network of its own laboratories and animal facilities. This scientific infrastructure is its key tangible asset. The chart shows the company's share of all laboratory capacity in the pharmaceutical testing sector.
Market segment balance sheet capitalization - Pharma tests
Below you can see the overall book value of the life sciences sector. Against this backdrop, Charles River Labs, a pharmaceutical research services provider, appears capital-intensive. Its business requires ownership of a network of laboratories and animal facilities worldwide, which is a significant barrier to entry.
Book value of all companies included in the broad market index - GURU.Markets
Charles River Laboratories owns an extensive network of laboratories and animal facilities where preclinical research is conducted for the entire pharmaceutical industry. Their assets provide the physical platform for developing new drugs. On the map of the world's scientific infrastructure, which can be visualized by looking at a graph, Charles River occupies a central position.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Charles River Laboratories
Charles River's balance sheet is the value of its global network of laboratories where new drugs are tested. The market values its unique position as a "funnel" through which nearly all pharmaceutical developments pass. The MvsBCap_Co chart shows how much more valuable this strategic position is than the value of the laboratories themselves.
Market to book capitalization ratio in a market segment - Pharma tests
Charles River Laboratories provides pharmaceutical research services, including preclinical testing. Its value lies in its laboratories and expertise. The chart shows the market premium placed on its reputation and integral role in the development of new drugs worldwide.
Market to book capitalization ratio for the market as a whole
Charles River Laboratories is a key partner for pharmaceutical and biotech companies, providing preclinical research services. Its value lies in its expertise, reputation, and unique research models. This chart shows how the market values service companies in knowledge-intensive industries, where intangible assets are more important than physical assets.
Debts of the company, segment and market as a whole
CRL - Company debts Charles River Laboratories
For Charles River Laboratories, a pharmaceutical research services provider, debt is a tool for expanding its services. This chart shows how the company uses debt to acquire additional laboratories and technologies to cover all stages of drug development. Debt helps them serve as a one-stop shop for the entire pharmaceutical industry.
Market segment debts - Pharma tests
Charles River Laboratories provides services to pharmaceutical and biotech companies, assisting them at all stages of drug development. Its R&D outsourcing business model requires investment in laboratories and scientific personnel. This chart allows you to evaluate how the company is funding its expansion and how its debt policy compares to the sector.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Charles River Laboratories
Charles River Laboratories provides preclinical research services to the pharmaceutical industry. This chart shows the financial structure of the company, whose business is integral to the drug discovery process. Its debt level reflects its growth strategy, which often includes acquiring smaller research organizations to expand its services.
Market segment debt to market segment book capitalization - Pharma tests
Charles River Laboratories is a key player in preclinical research for pharmaceutical companies. The chart reflects overall debt trends in the sector. It provides insight into how the company uses leverage to expand its services and acquire competitors, meeting the growing demand for R&D outsourcing in the pharmaceutical industry.
Debt to book value of all companies in the market
Charles River Labs, a pharmaceutical R&D partner, relies on innovative activity in biotech. The chart reflects the overall level of debt in the market. It allows one to assess whether demand for the company's services and its own M&A strategy are independent of macroeconomic cycles or whether they are slowing along with a general decline in risk appetite.
P/E of the company, segment and market as a whole
P/E - Charles River Laboratories
This chart for Charles River Laboratories reflects the state of the pharmaceutical industry. The company provides preclinical research services, and its P/E ratio rises when pharmaceutical companies actively invest in the development of new drugs. A decline in this ratio could signal a reduction in R&D budgets in the industry or increased competition among contract research organizations.
P/E of the market segment - Pharma tests
This chart shows the average P/E valuation for contract research organizations (CROs). For Charles River Labs, the market leader, this is an important benchmark. Its P/E valuation, which is higher than the industry average, underscores its scale, diversified services, and key role in the drug discovery process for the entire pharmaceutical industry.
P/E of the market as a whole
Charles River Laboratories is a contract research organization that assists pharmaceutical companies with preclinical drug testing. It is an integral part of the drug discovery process. This market assessment chart provides context for understanding whether Charles River is perceived as a sustainable service business, growing alongside the pharmaceutical industry.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Charles River Laboratories
Charles River Laboratories is a contract research organization providing services across all stages of drug development, from preclinical studies to manufacturing. The company's future growth depends on its activity in the pharmaceutical and biotech industries. This chart reflects investor confidence in R&D outsourcing and the stable demand for the company's services from pharmaceutical giants.
%20P%2FE%20Charles%20River%20Laboratories&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Charles-River-Laboratories&v=1772505848590 "Chart of the company's future (projected) P/E Charles River Laboratories")
Future (projected) P/E of the market segment - Pharma tests
Charles River Laboratories is an outsourcing organization providing services to pharmaceutical and biotech companies across all stages of drug development, from research to trials. It is a vital part of the pharma ecosystem. The chart reflects average expectations for the sector, allowing one to assess how the market views Charles River's prospects amid rising R&D costs in the industry.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-tests&v=1772505848595 "Future (projected) P/E graph of the market segment - Pharma tests")
Future (projected) P/E of the market as a whole
Charles River Laboratories provides services to pharmaceutical and biotech companies at all stages of drug development. Their business is science outsourcing. This graph of overall expectations is important, as market optimism drives investment in R&D. The more funding the biotech sector attracts, the more research it outsources to partners like Charles River.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772505848615 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Charles River Laboratories
Charles River Laboratories is a contract research organization providing services at all stages of drug development. This chart reflects outsourcing trends in the pharmaceutical industry. The company's profits are growing alongside rising R&D spending in the biopharmaceutical industry, as many companies choose to outsource preclinical research.
Profit of companies in the market segment - Pharma tests
Charles River Laboratories provides preclinical research services to pharmaceutical and biotech companies. The profitability of this outsourcing business is directly dependent on the volume of investment in new drug development. The data here demonstrates how activity in the pharmaceutical R&D sector generates stable demand and profitability for service companies.
Overall market profit
Charles River Laboratories is a contract research organization providing services to the pharmaceutical and biotechnology industries. The company plays a key role in the development of new drugs. Demand for its services is stable and driven by the volume of R&D investment, making its business less dependent on short-term market cycles.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Charles River Laboratories
Charles River Laboratories provides services and laboratory models for preclinical research in the pharmaceutical and biotechnology industries. Its profit forecast depends on the level of investment in drug development. This chart reflects analyst expectations regarding R&D activity and the role of outsourcing in the drug discovery process.
%20profit%20of%20the%20company%20Charles%20River%20Laboratories&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Charles-River-Laboratories&v=1772505848646 "Graph of future (projected) profit of the company Charles River Laboratories")
Future (predicted) profit of companies in the market segment - Pharma tests
Charles River Laboratories is an outsourcing organization that helps pharmaceutical and biotech companies conduct preclinical research. This research plays an unseen but crucial role in the development of new drugs. This chart shows profitability forecasts for the sector. It reflects overall R&D activity, which directly impacts Charles River's revenue.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-tests&v=1772505848648 "Graph of future (predicted) profits of companies in a market segment - Pharma tests")
Future (predicted) profit of the market as a whole
Charles River Laboratories provides preclinical research services to pharmaceutical companies. Its business thrives when the biotech industry is actively developing new drugs. This chart, showing overall profit expectations, reflects the market's investment appetite. A positive outlook encourages capital inflows into biotech, leading to increased R&D activity and increased orders for Charles River.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772505848652 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Charles River Laboratories
Charles River Laboratories is a contract research organization providing services across all stages of drug development, from preclinical studies to manufacturing. Its revenue is driven by activity in the pharmaceutical and biotech industries. The chart illustrates how the market values this outsourcing business, which is integral to medical innovation.
P/S market segment - Pharma tests
Charles River Laboratories International is a leading contract research organization (CRO) providing services to the pharmaceutical and biotechnology industries. The company helps accelerate drug research and development. This chart reflects the industry average, providing insight into how the market values Charles River's key role in the R&D process.
P/S of the market as a whole
Charles River Laboratories is a contract research organization providing services at all stages of drug development. The company is a key partner for the entire pharmaceutical industry. This chart shows the average market revenue estimate, providing insight into how investors value the business model based on R&D outsourcing in biotech.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Charles River Laboratories
Charles River Laboratories is a key partner for pharmaceutical and biotech companies, providing preclinical research services. This chart reflects investor estimates of the company's future revenue. It also highlights expectations for R&D activity in the global pharmaceutical industry, which directly drives demand for Charles River's services.
%20P%2FS%20Charles%20River%20Laboratories&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Charles-River-Laboratories&v=1772505848676 "The graph of the company's future (projected) P/S Charles River Laboratories")
Future (projected) P/S of the market segment - Pharma tests
Charles River Laboratories is a contract research organization providing services in the early stages of drug development. This chart compares the company's estimated future sales with its industry. It helps understand how investors view the extent of R&D outsourcing by pharmaceutical companies, which directly impacts Charles River's business.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20tests&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-tests&v=1772505848684 "Future (projected) P/S market segment graph - Pharma tests")
Future (projected) P/S of the market as a whole
Investor sentiment regarding future earnings is heavily dependent on the pharmaceutical industry, specifically the drug development process. Charles River Laboratories, a provider of preclinical research services, is a critical link in this chain. Demand for its services reflects how actively pharmaceutical companies are investing in new drugs, which is a leading indicator.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772505848686 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Charles River Laboratories
Charles River Laboratories is a contract research organization that assists pharmaceutical companies in developing new drugs. Revenue is generated by providing services at all stages of R&D, from preclinical studies to testing. This chart reflects activity and investment in the global pharmaceutical and biotech industries.
Sales of companies in the market segment - Pharma tests
Charles River Laboratories is a key partner for pharmaceutical and biotech companies, providing services across all stages of drug development, from preclinical studies to testing. This chart reflects overall revenue in the R&D outsourcing sector. It demonstrates how increased investment in new drug development is driving demand for Charles River's services.
Overall market sales
Charles River Laboratories is a contract research organization providing services to the pharmaceutical and biotechnology industries at all stages of drug development. Demand for its services is directly dependent on the volume of R&D in the pharmaceutical industry. This graph of the overall economic situation reflects investment activity in the healthcare sector, which funds the development of new drugs.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Charles River Laboratories
Charles River Laboratories is a contract research organization that helps pharmaceutical companies conduct preclinical trials of new drugs. Its revenue is driven by its R&D activity. This chart reflects analyst revenue expectations, which serve as a barometer of investment in drug development across the biopharmaceutical industry.
%20sales%20of%20the%20company%20Charles%20River%20Laboratories&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Charles-River-Laboratories&v=1772505848709 "Schedule of future (projected) sales of the company Charles River Laboratories")
Future (projected) sales of companies in the market segment - Pharma tests
Charles River Laboratories provides services to the pharmaceutical and biotechnology industries, including preclinical research and laboratory testing. The company is a vital link in the drug development process. This chart reflects projected sales for the entire pharmaceutical testing sector, allowing for an assessment of overall expectations for R&D activity and biotech investment.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-tests&v=1772505848715 "Schedule of future (projected) sales of companies in the market segment - Pharma tests")
Future (projected) sales of the market as a whole
Charles River Laboratories is a key partner for pharmaceutical companies, providing preclinical research services. Demand for its services directly depends on the volume of R&D in the global pharmaceutical industry. This chart provides an overview of the overall investment climate, which determines how much biotech and pharmaceutical companies are willing to invest in the development of new drugs.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772505848719 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Charles River Laboratories
Charles River Laboratories is a key partner for pharmaceutical companies, providing preclinical research services. This chart demonstrates the profitability of this outsourcing business. It reflects the percentage of research contract revenue the company converts into net profit, demonstrating its operational efficiency and the demand for its services.
Market segment marginality - Pharma tests
Charles River Laboratories is a contract research organization providing services across all stages of drug development. The company is an integral part of the pharmaceutical ecosystem. This chart shows its operational efficiency relative to its peers, reflecting its ability to deliver in-demand services with high profitability, demonstrating its key role in the industry.
Market marginality as a whole
#VALUE!
Employees in the company, segment and market as a whole
Number of employees in the company Charles River Laboratories
Charles River Laboratories provides outsourcing services to the pharmaceutical and biotechnology industries, primarily in preclinical research. This chart shows how the company is scaling its scientific staff to meet demand. Growing its team of lab technicians and scientists means an increase in the number of research contracts.
Share of the company's employees Charles River Laboratories within the market segment - Pharma tests
Charles River Laboratories is a key partner for pharmaceutical companies in preclinical research. This chart shows the proportion of scientists and laboratory technicians employed by the company in its contract research sector. Its vast workforce is the foundation upon which the majority of new drug development worldwide is built.
Number of employees in the market segment - Pharma tests
Charles River Laboratories is a contract research organization providing services to the pharmaceutical and biotech industries across all stages of drug development. This chart shows overall employment in the preclinical research sector. The increase indicates increased investment in R&D, which directly translates into increased orders for Charles River.
Number of employees in the market as a whole
Charles River Laboratories provides preclinical research services to pharmaceutical and biotech companies. This graph shows that the company's growth depends on its R&D activity. The more new drugs its clients have in development, the more laboratory technicians and scientists Charles River requires to conduct safety and efficacy testing.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Charles River Laboratories (CRL)
Charles River Laboratories is a contract research organization that helps pharmaceutical companies test drugs. This graph shows that its value is a combination of its laboratories (assets) and, more importantly, the expertise of thousands of scientists. This metric reflects the balance between research intensity and the need for a large staff to conduct research.
%20of%20the%20company%20Charles%20River%20Laboratories%20(CRL)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Charles-River-Laboratories-CRL&v=1772505848756 "Chart of market capitalization per employee (in thousands of dollars) of the company Charles River Laboratories (CRL)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma tests
Charles River Laboratories is a contract research organization (CRO). They provide services (including preclinical animal testing) for pharmaceutical companies. They are a "people-heavy" research company. This metric, compared to the industry average, reflects the premium the market pays for the expertise of their scientists and technicians.
%20by%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-tests&v=1772505848763 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma tests")
Market capitalization per employee (in thousands of dollars) for the overall market
Charles River Laboratories provides preclinical research services to the pharmaceutical industry. It is a knowledge-intensive service business. The company's cost per employee reflects its unique expertise and reputation. Investors value the ability of thousands of scientists and technicians to conduct the complex research necessary for the development of new drugs.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772505848768 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Charles River Laboratories (CRL)
Charles River Laboratories is a contract research organization (CRO). They provide pharmaceutical and biotech companies with services essential for drug development (such as preclinical testing). Their business is science as a service. This chart shows how much net profit each contract scientist and lab technician generates.
%20Chart%20Charles%20River%20Laboratories%20(CRL)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Charles-River-Laboratories-CRL&v=1772505848772 "Company Profit Per Employee (in thousands of dollars) Chart Charles River Laboratories (CRL)")
Profit per employee (in thousands of dollars) in the market segment - Pharma tests
Charles River (CRL) is a giant "CRO" (contract research organization). They "outsource" R&D for pharma (preclinical trials). This chart shows the benchmark for "Pharma testing." It's an "outsourced R&D business." Average profit per employee (scientist, analyst) depends on the lab workload.
%20in%20the%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-tests&v=1772505848785 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma tests")
Profit per employee (in thousands of dollars) for the market as a whole
Charles River Laboratories (CRL) is a contract research organization (CRO). They provide services to pharmaceutical and biotech companies, assisting them throughout all stages of drug development (from preclinical testing). This chart, showing average profit per employee, is important. It helps us understand how profitable the R&D outsourcing sector, where scientists are the primary asset, is relative to its workforce.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772505848790 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Charles River Laboratories (CRL)
For Charles River Laboratories, a contract research organization, this chart shows the effectiveness of its scientific and laboratory operations. It reflects how effectively the company provides services to pharmaceutical and biotech companies, helping them develop new drugs.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Charles-River-Laboratories-CRL&v=1772505848802 "Sales chart per company employee Charles River Laboratories (CRL)")
Sales per employee in the market segment - Pharma tests
Charles River Laboratories is a contract research organization (CRO) providing preclinical research services to pharmaceutical companies. Their business is scientific services. This metric reflects the average revenue per employee by segment. It helps assess how productive their labs and scientists are in generating revenue compared to other CROs.
Sales per employee for the market as a whole
Charles River Laboratories (CRL) is a key player in preclinical research. They provide services (including testing) to pharmaceutical companies for the development of new drugs. This metric reflects the efficiency of their laboratories. The growth in revenue per employee indicates high demand for their R&D outsourcing services and the company's ability to conduct more research without inflating its scientific staff.
Short shares by company, segment and market as a whole
Shares shorted by company Charles River Laboratories (CRL)
Charles River Laboratories is a key contract researcher (CRO) providing preclinical testing services (including animal testing) to the pharmaceutical industry. Its business relies on biotech funding. This chart reflects the potential for a slowdown in venture capital funding in biotech, which will reduce R&D budgets, as well as the ethical risks associated with its business model.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Charles-River-Laboratories-CRL&v=1772505848815 "Short Shares Chart for the Company Charles River Laboratories (CRL)")
Shares shorted by market segment - Pharma tests
Charles River Laboratories (CRL) is a contract research organization (CRO) that provides services to pharmaceutical companies in the preclinical stage of drug development (e.g., animal testing). This chart summarizes short positions in the CRO sector. It highlights market concerns about the level of funding for biotech companies, CRL's primary clients.
Shares shorted by the overall market
Charles River Labs (CRL) is a contract research organization that conducts preclinical trials for biotechs. When Short_All rises, it signals "risk aversion." This pessimism dries up venture capital funding for small biotechs. As a result, they have no money left for outsourcing research—CRL's core business.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Charles River Laboratories (CRL)
Charles River Labs is the largest contract research organization (CRO) providing preclinical testing services to the pharmaceutical industry. Business is a barometer of R&D. This chart, with a CRL above 70, may reflect a boom in biotech. A CRL below 30 is often associated with fears of a decline in R&D (a "venture winter").
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Charles-River-Laboratories-CRL&v=1772505848830 "RSI 14 indicator chart for the company's stock Charles River Laboratories (CRL)")
RSI 14 Market Segment - Pharma tests
Charles River Laboratories is a contract research organization (CRO) providing preclinical research and drug development services. They help pharmaceutical companies test the safety and efficacy of their drugs. This chart reflects the overall state of the CRO sector and helps understand whether the entire segment is being oversold amid changes in biotech R&D budgets.
RSI 14 for the overall market
Charles River Labs is a contract research outsourcing organization (CRO) that provides preclinical research services (e.g., lab animal testing). Pharmaceutical companies outsource this work to them. Demand depends on biotech R&D budgets. This panic indicator is important: when the market is in fear, small biotechs run out of money and are the first to cut contracts with CRLs.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast CRL (Charles River Laboratories)
Charles River Labs (CRL) is a contract research organization (CRO). They serve as an outsourced R&D partner for pharmaceutical and biotech companies, conducting preclinical drug trials. This chart is a collective 12-month forecast from analysts. It reflects their expectations for biotech R&D budgets and early-stage drug development outsourcing.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-CRL-Charles-River-Laboratories&v=1772505848842 "A chart showing analyst consensus forecasts for the expected stock price. CRL (Charles River Laboratories)")
The difference between the consensus estimate and the actual stock price CRL (Charles River Laboratories)
Charles River Laboratories (CRL) is a contract research organization (CRO) that provides services (from preclinical animal testing to manufacturing) to pharmaceutical companies. This chart shows the outsourcing of R&D. It measures the gap between the price and the consensus target, reflecting the potential analysts see in increased biotech spending.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-CRL-Charles-River-Laboratories&v=1772505848846 "A chart showing the difference between the consensus forecast and the actual stock price. CRL (Charles River Laboratories)")
Analyst consensus forecast for stock prices by market segment - Pharma tests
Charles River Laboratories (CRL) is one of the largest contract research organizations (CROs) specializing in preclinical testing (animal testing). This chart shows analysts' overall expectations for the pharma testing sector. It reflects whether experts believe biotech R&D budgets will grow or decline.
Analysts' consensus forecast for the overall market share price
Charles River Laboratories (CRL) is the gold standard in preclinical research. They are a CRO that tests drugs (including on animals) before human trials. Market expectations, as shown in this graph, influence R&D budgets. If the market is pessimistic, biotechs (their clients) receive less money and cut back on preclinical programs.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Charles River Laboratories
Charles River Laboratories (CRL) is a key outsourcing partner (CRO) for the entire pharmaceutical industry. They provide services at the earliest, preclinical stages of R&D, including animal testing. This chart is a barometer of biotech R&D budgets. Its dynamics directly depend on the level of funding in the biotech sector and the activity of new drug development.
AKIMA Market Segment Index - Pharma tests
Charles River is an unseen giant in R&D; the company is a leader in preclinical research (CRO), supplying lab animals and outsourcing early-stage drug testing. This composite metric evaluates companies. The graph shows the sector average. This benchmark: how does Charles River's indispensable role in early R&D differentiate it from the average competitor?
The AKIM Index for the overall market
Charles River is a contract research organization (CRO). It is the gold standard in providing animal models (mice) for preclinical drug testing. This chart, reflecting the market average, is a backdrop. It helps assess how CROs, a defense business dependent on biotech R&D budgets, compares to the overall macroeconomic picture.
